Abstract:113 Purpose: For ischaemic stroke, thrombolysis is usually be chosen to improve the clinical outcome, however the induced reperfusion injury is a potential factor of poorer recovery. Oxidative stress is one factor which can leading to cell damage and death via reactive oxygen species (ROS) thus antioxidant strategies have been used in the treatment of stroke. In this study, Fe-GA coordination polymer nanoparticles (Fe-GA NCPs) were developed for an antioxidative neuroprotector in the ischemia stroke rat model and evaluated using PET/MR imaging. Methods: The ultra-small Fe-GA NCPs were synthesized and tested by transmission electric microscope (TEM) and dynamic light scattering. Their antioxidative effect were further evaluated by the degradation of methylene blue (MB), the coloration of tetramethylbenzidine (TMB), the reduction of 1,1-diphenyl-2-picrylhydrazyl (DPPH) and the electron spin resonance (ESR) spectroscopy in vitro. To investigate the neuroprotective effects of Fe-GA NCPs nanoparticles in vivo, we induced ischemic stroke in rats and subsequently injection before reperfusion which mimicked the pathologic process in clinic. Adult Sprague-Dawley male rats were performed middle cerebral artery occlusion (MCAO), and reperfusion was performed 90 min after MCAO. Fe-GA encephalic injection was performed 1h before reperfusion under standard operation. 24 h after reperfusion, all rats underwent neurologic testing followed by neurologic function scale, 18F-FDG small animal PET (Philips), PET/MR (Siemens) scanning, 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxylin-eosin (HE) staining and oxidative stress testing. Normal, sham operation, MCAO only, saline (NS), and edaravone were performed as control groups and evaluated as well. Results: Fe-GA NCPs were synthesized using a simple chemical process. TEM images revealed discrete and uniform 7 nm-sized nanoparticles. As proved by MB, TMB, DPPH, and ESR spectroscopy, the ultra-small Fe-GA NCPs could significantly scavenge the reactive oxygen/nitrogen species. After treated with Fe-GA NCPs, the neurological score was better than other control groups. For MCAO model, 18F-FDG PET/MR could show the low FDG uptake in the region of brain infarct and high signal in T2-weighted MRI imaging. We found that brain infarct volumes in rats treated with Fe-GA NCPs decreases significantly than other negative groups. Its therapeutic effect was even better than same concentration of edaravone which is used in clinic for same purpose. Further, TTC staining verified these in vivo imaging results. The areas of infarct lesion showed by PET/MRI were correlated with TTC staining results, suggesting PET/MRI could be effectively used for evaluation. HE staining also showed the shape and structure of infarct brain were abnormal. Finally, oxidative stress was tested for oblated brain tissue and found less ROS level in Fe-GA NCPs treated rats. Conclusions: Fe-GA CPNs exhibit an impressive antioxidative neuroprotective role in ischemia stroke, which might have the potential to be translated into clinical applications for improved treatment of patients with stroke. PET/MRI is effective and accurate method for ischemic evaluation.

Preparation of Fe3 O4 Nanoparticles and Lentiviral Vector Infected EPCs for the Improvement of Angiogenesis and MRI Tracing

Preparation and Biological Characterization of Hollow Magnetic Fe3O4@C Nanoparticles As Drug Carriers with High Drug Loading Capability, Ph-Control Drug Release and MRI Properties

Influence on bionomics of endothelial progenitor cells labeling with magnetic nanoparticles

[In Vitro MR Imaging of Fe2O3-arginine Labeled Henos Gene Modified Endothelial Progenitor Cells].

[In Vitro MR Imaging of Fe(2)O(3)-PLL Labelled Rabbit Peripheral Blood Endothelial Progenitor Cells].

Multifunctional Nanoparticles of Fe3O4@SiO2(FITC)/PAH Conjugated the Recombinant Plasmid of Pirse2-Egfp/vegf165with Dual Functions for Gene Delivery and Cellular Imaging

Multifunctional nanoparticles of Fe(3)O(4)@SiO(2)(FITC)/PAH conjugated the recombinant plasmid of pIRSE2-EGFP/VEGF(165) with dual functions for gene delivery and cellular imaging.

Construction of Bfgf/heparin and Fe3O4 Nanoparticles Functionalized Scaffolds Aiming at Vascular Repair and Magnetic Resonance Imaging Monitoring

Polyol Synthesis of Superparamagnetic Fe_3O_4 Nanoparticles for Magnetic Resonance Imaging

In Vitro Labeling Of Endothelial Progenitor Cells Isolated From Peripheral Blood With Superparamagnetic Iron Oxide Nanoparticles

Polyetherimide-Grafted Fe3o4@Sio2 Nanoparticles As Theranostic Agents for Simultaneous Vegf Sirna Delivery and Magnetic Resonance Cell Imaging

Preparation and Imaging Study of Tumor-Targeting Mri Contrast Agent Based on Fe3o4 Nanoparticles

Developing Fe3O4 nanoparticles into an efficient multimodality imaging and therapeutic probe.

Synthesis of well-dispersed aqueous-phase magnetite nanoparticles and their metabolism as an MRI contrast agent for the reticuloendothelial system

VCAM-1-targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitro.

Study on MR Imaging of Endothelial Progenitor Cells Labeled with the Complex of Super Paramagnetic Iron Oxide and Transfection

Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy

Preparation and in vitro evaluation of PEG-coated superparamagnetic iron oxide nanoparticles

Effect of Gold/Fe 3 O 4 Nanoparticles on Biocompatibility and Neural Differentiation of Rat Olfactory Bulb Neural Stem Cells

Antioxidative Neuroprotective Role Of Iron-Gallic Acid Coordination Nanoparticles And Pet/Mr Usage In An Ischemia Stroke Model

Functionalized Iron Oxide Nanoparticles for Both Dual-Modal Imaging and Erythropoiesis